Home › Colorectal Cancer › Pennsylvania › Reading
Colorectal Cancer clinical trials in Reading, PA
3 studies for Colorectal Cancer are looking for participants at sites in and around Reading (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Penn State Health Saint Joseph Medical Center, Reading
- Reading Hospital, West Reading · 1 mi away
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecruitingPhase 3
- Clinical Study Site, Lebanon · 26 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY77 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA38 studies
- Seattle, WA34 studies
Other studies in Reading
- Lung Cancer11 studies
- Non-Small Cell Lung Cancer9 studies
- Acute Myeloid Leukemia5 studies
- Breast Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Prostate Cancer4 studies
- Cancer (all types)4 studies
- Narcolepsy3 studies
- Sleep Disorders3 studies
- Fatigue3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.